Comparing cemacabtagene ansegedleucel with Foresight CLARITY™ IUO MRD test, for large b-cell lymphoma
Explore this study →
Sites in Montreal, Calgary and 3 more cities
RecruitingPHASE2
Official title: Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma · Allogene Therapeutics